News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
879,264 Results
Type
Article (88560)
Company Profile (742)
Press Release (789930)
Multimedia
Podcasts (230)
Webinars (35)
Section
Business (233499)
Career Advice (4156)
Deals (39956)
Drug Delivery (172)
Drug Development (91587)
Employer Resources (207)
FDA (18512)
Job Trends (17474)
News (398477)
Policy (40007)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (3039)
Academic (1)
Accelerated approval (50)
Adcomms (39)
Allergies (184)
Alliances (56985)
ALS (224)
Alzheimer's disease (1927)
Antibody-drug conjugate (ADC) (493)
Approvals (18803)
Artificial intelligence (763)
Autoimmune disease (309)
Automation (60)
Bankruptcy (406)
Best Places to Work (12624)
BIOSECURE Act (23)
Biosimilars (238)
Biotechnology (454)
Bladder cancer (190)
Brain cancer (77)
Breast cancer (782)
Cancer (6101)
Cardiovascular disease (520)
Career advice (3589)
Career pathing (49)
CAR-T (361)
CDC (73)
Celiac Disease (3)
Cell therapy (992)
Cervical cancer (48)
Clinical research (78364)
Collaboration (2245)
Company closure (8)
Compensation (1432)
Complete response letters (101)
COVID-19 (3025)
CRISPR (119)
C-suite (1197)
Cystic fibrosis (163)
Data (8034)
Decentralized trials (3)
Denatured (87)
Depression (182)
Dermatology (88)
Diabetes (622)
Diagnostics (7489)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (362)
Drug pricing (243)
Drug shortages (39)
Duchenne muscular dystrophy (300)
Earnings (102174)
Editorial (77)
Employer branding (25)
Employer resources (174)
Events (137426)
Executive appointments (1156)
FDA (22345)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (35)
Funding (1819)
Gene editing (261)
Generative AI (71)
Gene therapy (816)
GLP-1 (1238)
Government (5541)
Grass and pollen (8)
Guidances (412)
Healthcare (21067)
HIV (85)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (100)
Immunology and inflammation (344)
Immuno-oncology (104)
Indications (192)
Infectious disease (3391)
Inflammatory bowel disease (239)
Inflation Reduction Act (17)
Influenza (144)
Intellectual property (298)
Interviews (820)
IPO (17986)
IRA (61)
Job creations (5206)
Job search strategy (2870)
JPM (73)
Kidney cancer (21)
Labor market (112)
Layoffs (679)
Leadership (49)
Legal (10170)
Liver cancer (107)
Longevity (34)
Lung cancer (801)
Lymphoma (440)
Machine learning (62)
Management (66)
Manufacturing (1138)
MASH (205)
Medical device (15169)
Medtech (15291)
Mergers & acquisitions (23212)
Metabolic disorders (1673)
mRNA (249)
Multiple sclerosis (197)
NASH (24)
Neurodegenerative disease (463)
Neuropsychiatric disorders (121)
Neuroscience (3558)
Neurotech (1)
NextGen: Class of 2026 (7692)
Non-profit (5133)
Now hiring (79)
Obesity (813)
Opinion (363)
Ovarian cancer (227)
Pain (272)
Pancreatic cancer (310)
Parkinson's disease (383)
Partnered (37)
Patents (617)
Patient recruitment (698)
Peanut (67)
People (67710)
Pharmaceutical (132)
Pharmacy benefit managers (36)
Phase 1 (24216)
Phase 2 (34052)
Phase 3 (25613)
Pipeline (8826)
Policy (385)
Postmarket research (3558)
Preclinical (10907)
Press Release (72)
Prostate cancer (311)
Psychedelics (67)
Radiopharmaceuticals (348)
Rare diseases (1194)
Real estate (7458)
Recruiting (81)
Regulatory (30056)
Reports (77)
Research institute (2753)
Resumes & cover letters (653)
Rett syndrome (40)
RNA editing (27)
RSV (97)
Schizophrenia (189)
Series A (314)
Series B (225)
Service/supplier (28)
Sickle cell disease (121)
Special edition (31)
Spinal muscular atrophy (187)
Sponsored (55)
Startups (4364)
State (2)
Stomach cancer (20)
Supply chain (139)
Tariffs (104)
The Weekly (140)
Vaccines (1253)
Venture capital (122)
Weight loss (562)
Women's health (130)
Worklife (24)
Date
Today (218)
Last 7 days (948)
Last 30 days (3763)
Last 365 days (32278)
2026 (12980)
2025 (32246)
2024 (37737)
2023 (42564)
2022 (53928)
2021 (58721)
2020 (57664)
2019 (51336)
2018 (39119)
2017 (37189)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (101)
Alaska (7)
Arizona (387)
Arkansas (16)
Asia (52059)
Australia (9155)
California (13670)
Canada (3827)
China (1441)
Colorado (587)
Connecticut (593)
Delaware (417)
Europe (119951)
Florida (2028)
Georgia (444)
Hawaii (4)
Idaho (69)
Illinois (1156)
India (97)
Indiana (638)
Iowa (25)
Japan (553)
Kansas (139)
Kentucky (56)
Louisiana (45)
Maine (81)
Maryland (1671)
Massachusetts (9977)
Michigan (389)
Minnesota (753)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (30)
Nevada (148)
New Hampshire (90)
New Jersey (3623)
New Mexico (34)
New York (3586)
North Carolina (1850)
North Dakota (11)
Northern California (6775)
Ohio (424)
Oklahoma (26)
Oregon (53)
Pennsylvania (2725)
Puerto Rico (30)
Rhode Island (52)
South America (1668)
South Carolina (87)
South Dakota (2)
Southern California (5339)
Tennessee (215)
Texas (2190)
United States (48853)
Utah (409)
Vermont (1)
Virginia (352)
Washington D.C. (87)
Washington State (1120)
West Virginia (4)
Wisconsin (139)
Wyoming (2)
879,264 Results for "pharma bio serv inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
March 18, 2026
·
2 min read
Drug pricing
Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling
As Big Pharma companies consider foregoing European drug launches to avoid reducing drug prices in the U.S. in alignment with Trump’s Most Favored Nation policy, patients will suffer.
April 2, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Pharma-Bio Serv Announces Full Year Results and Special Dividend - January 29, 2026
January 30, 2026
·
3 min read
Press Releases
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026
·
5 min read
Startups
Altitude Labs serves up higher education for biotech founders
Altitude Labs, an offshoot of AI-focused techbio Recursion, is teaching scientists to build companies, one founder at a time.
April 29, 2026
·
5 min read
·
Annalee Armstrong
C-suite
Lilly, J&J CEOs top pharma’s highest paid list—again
Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by more than $4 million.
May 13, 2026
·
5 min read
·
Annalee Armstrong
Insights
ALS Advances Unite Patients and Pharma on Novel Targets, Biomarker Breakthroughs
In this episode of Denatured, you’ll be listening to Indu Navar, CEO and founder of EverythingALS and Dr. Olga Uspenskaya, chief medical officer at VectorY Therapeutics. We’ll be speaking about patient-pharma collaborations accelerating trials and hope, advances in ALS biology understanding and biomarker-driven endpoints.
February 26, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Mergers & acquisitions
Pharma Double-Dippers Lead Q1 Deal Activity to Nearly $47B
Deal-hungry Big Pharmas, a long-sought biotech prize, an infrequent buyer and one serial biotech rabblerouser highlight a busy quarter in biopharma M&A.
April 1, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025
June 17, 2025
·
2 min read
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
1 of 87,927
Next
